What is Medifast EBITDA Margin %?
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Medifast's EBITDA for the three months ended in Mar. 2024 was $11.2 Mil. Medifast's Revenue for the three months ended in Mar. 2024 was $174.7 Mil. Therefore, Medifast's EBITDA margin for the quarter that ended in Mar. 2024 was 6.41%.
Medifast EBITDA Margin % Historical Data
The historical data trend for Medifast's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Medifast EBITDA Margin % Chart
| Medifast Annual Data | ||||||||||||||||||||
| Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||||||
| EBITDA Margin % | Get a 7-Day Free Trial | 13.40 | 14.81 | 14.62 | 12.24 | 13.01 | ||||||||||||||
| Medifast Quarterly Data | ||||||||||||||||||||
| Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
| EBITDA Margin % | Get a 7-Day Free Trial | 16.19 | 14.21 | 12.26 | 6.30 | 6.41 | ||||||||||||||
Competitive Comparison of Medifast's EBITDA Margin %
For the Personal Services subindustry, Medifast's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medifast's EBITDA Margin % Distribution in the Personal Services Industry
For the Personal Services industry and Consumer Cyclical sector, Medifast's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Medifast's EBITDA Margin % falls into.
Medifast EBITDA Margin % Calculation
EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.
Medifast's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as
| EBITDA Margin % | = | EBITDA (A: Dec. 2023 ) | / | Revenue (A: Dec. 2023 ) |
| = | 139.509 | / | 1072.054 | |
| = | 13.01 % |
Medifast's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as
| EBITDA Margin % | = | EBITDA (Q: Mar. 2024 ) | / | Revenue (Q: Mar. 2024 ) |
| = | 11.201 | / | 174.739 | |
| = | 6.41 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medifast(NYSE:MED) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Medifast EBITDA Margin % Related Terms
Thank you for viewing the detailed overview of Medifast's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Medifast (Medifast) Business Description
Industry
GURUFOCUS.COM »STOCK LIST »Consumer Cyclical » Personal Services » Medifast Inc (NYSE:MED) » Definitions » EBITDA Margin %
Comparable Companies
WW CSV MUGH YYGH EJH RGS EVTK TRNR IVP PDRO ROL SCI HRB BFAM TSX:BYD FTDR MCW HKSE:01448 LSE:CVSG OHEL:MUSTI
Traded in Other Exchanges
MED:Mexico MDF:Germany MDF:Germany
Address
100 International Drive, Baltimore, MD, USA, 21202
Website
Medifast Inc is a United states based company that produces, distributes and sells products concerning weight loss, weight management, and healthy living. The company generates its revenue from point of sale transactions executed over an e-commerce platform for weight loss, weight management, and other consumable health and nutritional products.
Executives
| Jeffrey J Brown | director | 19900 MACARTHUR BLVD, SUITE 570, IRVINE CA 92612 |
| Andrea B Thomas | director | C/O MEDIFAST, INC., 100 INTERNATIONAL DRIVE, BALTIMORE MD 21202 |
| Michael A. ho*r | director | MEDIFAST, INC., 100 INTERNATIONAL DRIVE, 18TH FLOOR, BALTIMORE MD 21202 |
| Scott Schlackman | director | 3600 CRONDALL LANE, OWINGS MILLS MD 21117 |
| Hallquist Constance J. | director | 3600 CRONDALL LANE, OWINGS MILLS MD 21117 |
| Elizabeth A. Geary | director | C/O MEDIFAST, INC., 100 INTERNATIONAL DRIVE, BALTIMORE MD 21202 |
| Daniel R Chard | director, officer: Chief Executive Officer | NU SKIN ENTERPRISES, INC., 75 WEST CENTER STREET, PROVO UT 84601 |
| Jonathan Barrett Mackenzie | officer: VP, Finance & CAO | 100 INTERNATIONAL DRIVE, BALTIMORE MD 21202 |
| Kevin G Byrnes | director | C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117 |
| Michael C Macdonald | director | C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117 |
| James P. Maloney | officer: Chief Financial Officer | 415 HOLIDAY DRIVE, PITTSBURGH PA 15220 |
| Ming Xian | director | MEDIFAST, INC., 100 INTERNATIONAL DRIVE, 18TH FLOOR, BALTIMORE MD 21202 |
| Carl E Sassano | director | C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117 |
| Joseph P Kelleman | officer: (Interim) CFO | 3600 CRONDALL LANE, OWINGS MILLS MD 21117 |
| Timothy G Robinson | officer: Chief Financial Officer | C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117 |
Medifast (Medifast) Headlines
From GuruFocus
Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2022
By PRNewswire PRNewswire • 10-20-2022
Medifast Announces Quarterly Dividend
By PRNewswire PRNewswire • 06-15-2023
Medifast Named to the 2022 FORTUNE 100 Fastest-Growing Companies List
By PRNewswire PRNewswire • 11-16-2022
Medifast Announces Quarterly Dividend
By PRNewswire PRNewswire • 03-17-2023
Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2022
By PRNewswire PRNewswire • 02-07-2023
Medifast Expands into $30B Sports Nutrition Category with OPTAVIA ACTIVE�
By PRNewswire • 07-27-2023
Medifast to Announce Financial Results for the First Quarter Ended March 31, 2023
By PRNewswire PRNewswire • 04-17-2023
Health is Top Priority for Majority of U.S. Adults Despite Continuous Cycle of Failed Diets
By PRNewswire PRNewswire • 07-11-2022
Medifast Announces Quarterly Dividend
By PRNewswire PRNewswire • 12-08-2022
Medifast Opens Product Innovation Center as Company Anticipates Continued Rapid Growth
By PRNewswire PRNewswire • 07-09-2022
